日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leukemia

白血病干细胞特性和共存突变驱动急性髓系白血病对IDH抑制剂产生耐药性

Wang, Feng; Morita, Kiyomi; DiNardo, Courtney D; Furudate, Ken; Tanaka, Tomoyuki; Yan, Yuanqing; Patel, Keyur P; MacBeth, Kyle J; Wu, Bin; Liu, Guowen; Frattini, Mark; Matthews, Jairo A; Little, Latasha D; Gumbs, Curtis; Song, Xingzhi; Zhang, Jianhua; Thompson, Erika J; Kadia, Tapan M; Garcia-Manero, Guillermo; Jabbour, Elias; Ravandi, Farhad; Bhalla, Kapil N; Konopleva, Marina; Kantarjian, Hagop M; Andrew Futreal, P; Takahashi, Koichi

TP53 mutations in myelodysplastic syndromes and secondary AML confer an immunosuppressive phenotype

骨髓增生异常综合征和继发性急性髓系白血病中的TP53突变赋予了免疫抑制表型

Sallman, David A; McLemore, Amy F; Aldrich, Amy L; Komrokji, Rami S; McGraw, Kathy L; Dhawan, Abhishek; Geyer, Susan; Hou, Hsin-An; Eksioglu, Erika A; Sullivan, Amy; Warren, Sarah; MacBeth, Kyle J; Meggendorfer, Manja; Haferlach, Torsten; Boettcher, Steffen; Ebert, Benjamin L; Al Ali, Najla H; Lancet, Jeffrey E; Cleveland, John L; Padron, Eric; List, Alan F

Molecular remission and response patterns in patients with mutant-IDH2 acute myeloid leukemia treated with enasidenib

接受enasidenib治疗的突变型IDH2急性髓系白血病患者的分子缓解和反应模式

Stein, Eytan M; DiNardo, Courtney D; Fathi, Amir T; Pollyea, Daniel A; Stone, Richard M; Altman, Jessica K; Roboz, Gail J; Patel, Manish R; Collins, Robert; Flinn, Ian W; Sekeres, Mikkael A; Stein, Anthony S; Kantarjian, Hagop M; Levine, Ross L; Vyas, Paresh; MacBeth, Kyle J; Tosolini, Alessandra; VanOostendorp, Jason; Xu, Qiang; Gupta, Ira; Lila, Thomas; Risueno, Alberto; Yen, Katharine E; Wu, Bin; Attar, Eyal C; Tallman, Martin S; de Botton, Stéphane

Enasidenib, an inhibitor of mutant IDH2 proteins, induces durable remissions in older patients with newly diagnosed acute myeloid leukemia

Enasidenib 是一种突变型 IDH2 蛋白抑制剂,可使新诊断的急性髓系白血病老年患者获得持久缓解。

Pollyea, Daniel A; Tallman, Martin S; de Botton, Stéphane; Kantarjian, Hagop M; Collins, Robert; Stein, Anthony S; Frattini, Mark G; Xu, Qiang; Tosolini, Alessandra; See, Wendy L; MacBeth, Kyle J; Agresta, Samuel V; Attar, Eyal C; DiNardo, Courtney D; Stein, Eytan M

Isoform Switching as a Mechanism of Acquired Resistance to Mutant Isocitrate Dehydrogenase Inhibition

异构体转换作为获得对突变型异柠檬酸脱氢酶抑制剂耐药性的机制

Harding, James J; Lowery, Maeve A; Shih, Alan H; Schvartzman, Juan M; Hou, Shengqi; Famulare, Christopher; Patel, Minal; Roshal, Mikhail; Do, Richard K; Zehir, Ahmet; You, Daoqi; Selcuklu, S Duygu; Viale, Agnes; Tallman, Martin S; Hyman, David M; Reznik, Ed; Finley, Lydia W S; Papaemmanuil, Elli; Tosolini, Alessandra; Frattini, Mark G; MacBeth, Kyle J; Liu, Guowen; Fan, Bin; Choe, Sung; Wu, Bin; Janjigian, Yelena Y; Mellinghoff, Ingo K; Diaz, Luis A; Levine, Ross L; Abou-Alfa, Ghassan K; Stein, Eytan M; Intlekofer, Andrew M

p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q)

p53 蛋白表达可独立预测伴有 del(5q) 的低危骨髓增生异常综合征患者的预后

Saft, Leonie; Karimi, Mohsen; Ghaderi, Mehran; Matolcsy, András; Mufti, Ghulam J; Kulasekararaj, Austin; Göhring, Gudrun; Giagounidis, Aristoteles; Selleslag, Dominik; Muus, Petra; Sanz, Guillermo; Mittelman, Moshe; Bowen, David; Porwit, Anna; Fu, Tommy; Backstrom, Jay; Fenaux, Pierre; MacBeth, Kyle J; Hellström-Lindberg, Eva

Lenalidomide as a disease-modifying agent in patients with del(5q) myelodysplastic syndromes: linking mechanism of action to clinical outcomes

来那度胺作为del(5q)骨髓增生异常综合征患者的疾病修饰剂:作用机制与临床疗效的关联

Giagounidis, Aristoteles; Mufti, Ghulam J; Fenaux, Pierre; Germing, Ulrich; List, Alan; MacBeth, Kyle J

Phase I study of oral azacitidine in myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia

口服阿扎胞苷治疗骨髓增生异常综合征、慢性粒单核细胞白血病和急性髓系白血病的I期研究

Garcia-Manero, Guillermo; Gore, Steven D; Cogle, Christopher; Ward, Renee; Shi, Tao; Macbeth, Kyle J; Laille, Eric; Giordano, Heidi; Sakoian, Sarah; Jabbour, Elias; Kantarjian, Hagop; Skikne, Barry

Transcriptional responses to estrogen and progesterone in mammary gland identify networks regulating p53 activity.

乳腺对雌激素和孕激素的转录反应揭示了调控 p53 活性的网络

Lu Shaolei, Becker Klaus A, Hagen Mary J, Yan Haoheng, Roberts Amy L, Mathews Lesley A, Schneider Sallie S, Siegelmann Hava T, MacBeth Kyle J, Tirrell Stephen M, Blanchard Jeffrey L, Jerry D Joseph